Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 17 Sept 2026 for Travere Therapeutics, Inc., €502k. Read the official filing
Filing timeline
BuySaleElizabeth e. Reed
Insider track record
Disclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Elizabeth e. Reed: trading record in brief
Elizabeth e. Reed (board member) discloses dealings in Travere Therapeutics, Inc. to SEC (Form 4). In total, 38 filings cover trades dated from 11 May 2021 to 15 September 2026.
Every open-market trade on record is a sale: 17 sales worth €4.4M. The rest of the record consists of 10 share grants and 11 option exercises. Since January 2026: no purchases and 10 sales on the market.
The record was last updated on 17 September 2026 with an option exercise (€502k) in Travere Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Elizabeth e. Reed
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
37,500 shares@ US$15.46Common StockSEC:0001283303-26-000010:0
21,926 shares@ US$62.0255Common StockSEC:0001283303-26-000010:1
13,874 shares@ US$62.6326Common StockSEC:0001283303-26-000010:2
1,400 shares@ US$63.6902Common StockSEC:0001283303-26-000010:3
300 shares@ US$65.31Common StockSEC:0001283303-26-000010:4
14,000 shares0Common StockSEC:0001283303-26-000008:0
10,000 shares@ US$19.080.0034% mcap6.1% of flowCommon StockSEC:0001283303-26-000008:1
20,000 shares@ US$17.960.0065% mcap11.5% of flowCommon StockSEC:0001283303-26-000008:2
7,500 shares@ US$15.460.0021% mcap3.7% of flowCommon StockSEC:0001283303-26-000008:3
37,500 shares@ US$41.070.028% mcap49.2% of flowCommon StockSEC:0001283303-26-000008:4
7,215 shares@ US$41.92880.0054% mcap9.7% of flowCommon StockSEC:0001283303-26-000008:5
5,226 shares@ US$41.620.0039% mcap6.9% of flowCommon StockSEC:0001283303-26-000008:6
1,559 shares@ US$42.530.0012% mcap2.1% of flowCommon StockSEC:0001283303-26-000008:7
10,000 shares@ US$15.464.5% of flowCommon StockSEC:0001283303-26-000007:0
10,000 shares@ US$30.008.7% of flowCommon StockSEC:0001283303-26-000007:1
10,000 shares@ US$19.085.3% of flowCommon StockSEC:0001283303-26-000006:0
10,000 shares@ US$19.084.4% of flowCommon StockSEC:0001283303-26-000005:0
2,485 shares@ US$32.071.8% of flowCommon StockSEC:0001283303-26-000003:0
25,110 shares0Common StockSEC:0001283303-26-000002:0
10,000 shares@ US$19.084.4% of flowCommon StockSEC:0001283303-26-000001:0
10,000 shares@ US$19.084.9% of flowCommon StockSEC:0001283303-25-000005:0
4,920 sharesCommon StockSEC:0001415889-25-012054:0
8,000 sharesCommon StockSEC:0001415889-25-003823:0
21,500 shares0Common StockSEC:0001415889-25-003066:0
2,437 shares@ US$19.4616.0% of flowCommon StockSEC:0001415889-25-002004:0
25 of 38 declarations
